Egholm Michael's Form 4 filing
Standard Biotools Inc.LAB · filed May 22, 2025
- Accession no.
- 0000950170-25-076591
- Filed
- May 22, 2025
- Trade date
- May 20-21, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $4.86K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Egholm MichaelCIK 0001559779 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 20, 2025 | Common Stock | FTax withholdingDisposed | −18,343 | $1.05 | −$19,260.15 | 2,756,499 | Direct | |
| May 21, 2025 | Common Stock | SSaleDisposed | −4,719 | $1.03F3 | −$4,860.57 | 2,751,780 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Represents the weighted average sales price per share. The shares sold at prices ranging from $1.015 to $1.05 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the SEC, the Issuer, or a security holder of the Issuer.
Referenced by the price of 1 transaction in Table I.